Fig. 2From: Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patientsA/C [18F]AlF-OC and B/D [68Ga]Ga-DOTATATE images (from top to bottom: maximum-intensity projection PET and transverse PET) of a 60-year-old male patient with a history of resection of small intestinal NET, currently with liver metastases. Multiple liver lesions were called negative by [68Ga]Ga-DOTATATE and are shown by green arrows. Blue arrows indicate concordant lesionsBack to article page